<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2021.116395</article-id><article-id pub-id-type="publisher-id">ACM-43255</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20210600000_84858866.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  齐鲁医院分型诊治78例子宫瘢痕妊娠的临床观察
  Clinical Observation of 78 Cases of Cesarean Scar Pregnancy Diagnosed and Treated by Typing in Qilu Hospital
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>李</surname><given-names>冬梅</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>苏荣</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>刘</surname><given-names>天凤</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>临沂市人民医院妇科，山东 临沂</addr-line></aff><aff id="aff2"><addr-line>山东第一医科大学，山东 济南 </addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>01</day><month>06</month><year>2021</year></pub-date><volume>11</volume><issue>06</issue><fpage>2730</fpage><lpage>2737</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  目的：探讨齐鲁医院分型在治疗剖宫产术后子宫瘢痕妊娠(CSP)的临床疗效。方法：选取2020年1月至2020年12月在山东省临沂市人民医院妇科收治的78例CSP患者的临床资料，依据齐鲁医院分型诊治：分为I型组、IIa型组、IIb型组、IIIa型组、IIIb组及IIIc型组。分析各组患者的一般资料、临床疗效。结果：78例CSP患者均经我院经阴道超声进行明确诊断，依据齐鲁医院分型对于CSP患者进行诊治：I型29例，IIa型21例，IIb型6例，IIIa型10例，IIIb型11例，IIIc型1例。在CSP不同分型中年龄、距离上一次剖宫产时间比较，差异均无统计学意义(P &gt; 0.05)。不同分型中停经时间、剖宫产次数、术前β-HCG水平比较，差异有统计学意义(P &lt; 0.05)。74例CSP患者在术后2月内月经复潮，比例为94.87%，3例CSP患者需要二次手术，3例术中需要中转手术方式，总体治疗成功率为92.3% (72/78)。结论：对于CSP患者，依据齐鲁医院分型进行诊治，手术均获得了较好的治疗效果，无因术中大出血而切除子宫。此分型适用于临床，简便可行，能够对患者的病情充分地评估，推荐的治疗方案，成功率高，并发症少，值得进一步应用于临床及推广。
   Objective: To investigate the clinical efficacy of Qilu Hospital classification in the treatment of cesarean scar pregnancy (CSP). Methods: The clinical data of 78 patients with CSP admitted to the Department of Gynecology, Linyi People’s Hospital of Shandong Province from January 2020 to December 2020 were selected and divided into type I group, type IIa group, type IIb group, type IIIa group, and type IIIb IIIc group according to the classification of Qilu Hospital. The general data and clinical efficacy of patients in each group were analyzed. Results: Seventy-eight patients with CSP were diagnosed by transvaginal ultrasonography in our hospital. The patients with CSP were diagnosed and treated according to Qilu Hospital classification: 29 cases of type I, 21 cases of type IIa, 6 cases of type IIb, 10 cases of type IIIa, 11 cases of type IIIb, and 1 case of type IIIc. There were no significant differences in age or time from the last cesarean section among the different types of CSP (P &gt; 0.05). There were significant differences in menopause time, number of cesarean sections, and preoperative β-hCG levels among different types (P &lt; 0.05). Seventy-four CSP patients had resumption of menses within 2 months after surgery, with a proportion of 94.87%, 3 CSP patients required a second operation, and 3 patients required intraoperative conversion to surgical methods, with an overall treatment success rate of 92.3% (72/78). Conclusion: For patients with CSP, according to the classification of Qilu Hospital, the operation obtained a better therapeutic effect, and no uterus was removed due to intraoperative massive hemorrhage. This classification is suitable for clinical use, simple and feasible, and can fully evaluate the patient’s condition. The recommended treatment has high success rate, with fewer complications. It is worthy of further clinical application and promotion.
 
</p></abstract><kwd-group><kwd>剖宫产术后子宫瘢痕妊娠，齐鲁医院分型，手术治疗, Cesarean Scar Pregnancy</kwd><kwd> Qilu Hospital Classification</kwd><kwd> Surgical Treatment</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>目的：探讨齐鲁医院分型在治疗剖宫产术后子宫瘢痕妊娠(CSP)的临床疗效。方法：选取2020年1月至2020年12月在山东省临沂市人民医院妇科收治的78例CSP患者的临床资料，依据齐鲁医院分型诊治：分为I型组、IIa型组、IIb型组、IIIa型组、IIIb组及IIIc型组。分析各组患者的一般资料、临床疗效。结果：78例CSP患者均经我院经阴道超声进行明确诊断，依据齐鲁医院分型对于CSP患者进行诊治：I型29例，IIa型21例，IIb型6例，IIIa型10例，IIIb型11例，IIIc型1例。在CSP不同分型中年龄、距离上一次剖宫产时间比较，差异均无统计学意义(P &gt; 0.05)。不同分型中停经时间、剖宫产次数、术前β-HCG水平比较，差异有统计学意义(P &lt; 0.05)。74例CSP患者在术后2月内月经复潮，比例为94.87%，3例CSP患者需要二次手术，3例术中需要中转手术方式，总体治疗成功率为92.3% (72/78)。结论：对于CSP患者，依据齐鲁医院分型进行诊治，手术均获得了较好的治疗效果，无因术中大出血而切除子宫。此分型适用于临床，简便可行，能够对患者的病情充分地评估，推荐的治疗方案，成功率高，并发症少，值得进一步应用于临床及推广。</p></sec><sec id="s2"><title>关键词</title><p>剖宫产术后子宫瘢痕妊娠，齐鲁医院分型，手术治疗</p></sec><sec id="s3"><title>Clinical Observation of 78 Cases of Cesarean Scar Pregnancy Diagnosed and Treated by Typing in Qilu Hospital<sup> </sup></title><p>Dongmei Li<sup>1</sup>, Surong Wang<sup>2</sup>, Tianfeng Liu<sup>2</sup></p><p><sup>1</sup>Shandong First Medical University, Jinan Shandong</p><p><sup>2</sup>Department of Gynecology, Linyi People’s Hospital, Linyi Shandong</p><p>Received: May 17<sup>th</sup>, 2021; accepted: Jun. 3<sup>rd</sup>, 2021; published: Jun. 21<sup>st</sup>, 2021</p><p><img src="//html.hanspub.org/file/37-1572323x5_hanspub.png" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>Objective: To investigate the clinical efficacy of Qilu Hospital classification in the treatment of cesarean scar pregnancy (CSP). Methods: The clinical data of 78 patients with CSP admitted to the Department of Gynecology, Linyi People’s Hospital of Shandong Province from January 2020 to December 2020 were selected and divided into type I group, type IIa group, type IIb group, type IIIa group, and type IIIb IIIc group according to the classification of Qilu Hospital. The general data and clinical efficacy of patients in each group were analyzed. Results: Seventy-eight patients with CSP were diagnosed by transvaginal ultrasonography in our hospital. The patients with CSP were diagnosed and treated according to Qilu Hospital classification: 29 cases of type I, 21 cases of type IIa, 6 cases of type IIb, 10 cases of type IIIa, 11 cases of type IIIb, and 1 case of type IIIc. There were no significant differences in age or time from the last cesarean section among the different types of CSP (P &gt; 0.05). There were significant differences in menopause time, number of cesarean sections, and preoperative β-hCG levels among different types (P &lt; 0.05). Seventy-four CSP patients had resumption of menses within 2 months after surgery, with a proportion of 94.87%, 3 CSP patients required a second operation, and 3 patients required intraoperative conversion to surgical methods, with an overall treatment success rate of 92.3% (72/78). Conclusion: For patients with CSP, according to the classification of Qilu Hospital, the operation obtained a better therapeutic effect, and no uterus was removed due to intraoperative massive hemorrhage. This classification is suitable for clinical use, simple and feasible, and can fully evaluate the patient’s condition. The recommended treatment has high success rate, with fewer complications. It is worthy of further clinical application and promotion.</p><p>Keywords:Cesarean Scar Pregnancy, Qilu Hospital Classification, Surgical Treatment</p><disp-formula id="hanspub.43255-formula31"><graphic xlink:href="//html.hanspub.org/file/37-1572323x6_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2021 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/37-1572323x7_hanspub.png" /> <img src="//html.hanspub.org/file/37-1572323x8_hanspub.png" /></p></sec><sec id="s5"><title>1. 引言</title><p>剖宫产术后瘢痕妊娠(Cesarean scar pregnancy, CSP)是剖宫产术后严重的远期并发症之一，是再次妊娠时受精卵着床于既往剖宫产术后的子宫切口瘢痕处、具有限时定义(早孕期 ≤ 12周)的一种特殊类型的异位妊娠。在临床上，CSP诊治不及时可在孕晚期形成凶险型前置胎盘、胎盘植入，有大出血、子宫破裂，周围的脏器损伤，严重者有子宫的切除、死亡的风险 [<xref ref-type="bibr" rid="hanspub.43255-ref1">1</xref>]。CSP的发病率 [<xref ref-type="bibr" rid="hanspub.43255-ref2">2</xref>] [<xref ref-type="bibr" rid="hanspub.43255-ref3">3</xref>] 被报道为1:2216~1:1688。</p><p>近年来，随着我国二孩政策的开放以及较高的剖宫产率，CSP的发生率呈逐年升高的趋势。目前国内外对于CSP的诊断及治疗尚未有统一的标准和指南，如何安全、有效及个体化地诊治不同分型的CSP患者，以免造成不必要的并发症，已成为了临床上的重点关注。本研究回顾性分析了临沂市人民医院妇科依据齐鲁医院分型(实际的临床处理选择)进行诊治的78例CSP患者的临床资料，现报道如下。</p></sec><sec id="s6"><title>2. 资料与方法</title><sec id="s6_1"><title>2.1. 临床资料</title><p>收集2020年1月至2020年12月在山东省临沂市人民医院妇科依据齐鲁医院分型进行诊治的CSP患者的病例资料，一共78例。患者的年龄21~43岁，平均(33.65 &#177; 4.54)岁；停经时间30~83天，平均(53.15 &#177; 11.46)天；剖宫产次数1~3次，平均(1.81 &#177; 0.60)次；距离上一次剖宫产时间1~18年，平均(4.76 &#177; 3.44)年；孕囊或包块平均直径大小4.33~61 mm，平均(25.86 &#177; 13.79) mm。纳入标准：1) 患者既往均有剖宫产的手术史；2) 患者具有停经史，尿妊娠试验为阳性，血清β人绒毛膜促性腺激素(β-HCG)水平升高；3) 患者术前的超声检查符合CSP的诊断；4) 依据齐鲁医院分型进行手术治疗；5) 患者均签署知情同意书，要求手术终止妊娠。排除标准：1) 有全身严重感染等其他的手术禁忌证；2) 孕周 &gt; 12周。</p></sec><sec id="s6_2"><title>2.2. 诊疗方案</title><p>齐鲁医院分型是其多年来对于CSP患者在临床上的实际处理选择。具体诊疗方案见表1。</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Actual clinical treatment of CSP in Qilu Hospita</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >最小前壁的肌层厚度</th><th align="center" valign="middle" >妊娠囊或包块平均直径</th><th align="center" valign="middle" >临床实际处理的手术方式</th></tr></thead><tr><td align="center" valign="middle" >I型</td><td align="center" valign="middle" >≥3 mm</td><td align="center" valign="middle" >无论大小</td><td align="center" valign="middle" >超声监视下吸宫术 &#177; 宫腔镜手术</td></tr><tr><td align="center" valign="middle"  rowspan="4"  >II型</td><td align="center" valign="middle"  rowspan="4"  >1~3 mm</td><td align="center" valign="middle" >a ≤ 3 cm</td><td align="center" valign="middle" >超声监视下吸宫术 + 宫腔镜手术</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >b &gt; 3 cm</td><td align="center" valign="middle" >腹腔镜监视下吸宫术 + 宫腔镜手术</td></tr><tr><td align="center" valign="middle" >或经阴道前穹隆切开病灶清除术</td></tr><tr><td align="center" valign="middle" >必要时瘢痕缺陷修补或经阴手术</td></tr><tr><td align="center" valign="middle"  rowspan="5"  >III型</td><td align="center" valign="middle"  rowspan="5"  >&lt;1 mm</td><td align="center" valign="middle"  rowspan="2"  >a ≤ 6 cm，活胚孕囊</td><td align="center" valign="middle" >腹腔镜下瘢痕妊娠病灶清除术 + 吸宫术</td></tr><tr><td align="center" valign="middle" >或经阴道前穹隆切开病灶清除术</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >b ≤ 6 cm，停育孕囊或混合性包块</td><td align="center" valign="middle" >腹腔镜下瘢痕妊娠病灶清除术 + 吸宫术</td></tr><tr><td align="center" valign="middle" >或经阴前穹隆切开病灶清除术</td></tr><tr><td align="center" valign="middle" >c &gt; 6 cm，或伴有动静脉瘘</td><td align="center" valign="middle" >开腹手术或子宫动脉栓塞后腹腔镜手术</td></tr></tbody></table></table-wrap><p>表1. 齐鲁医院分型CSP的实际临床处理</p></sec><sec id="s6_3"><title>2.3. 评价指标</title><p>记录术中出血量、手术时间、住院天数、住院总费用、子宫动脉栓塞率，宫腔内球囊压迫、输血治疗、残留及二次手术情况，术后β-HCG下降水平及恢复正常时间，术后月经复潮时间及治疗成功率等指标。</p></sec><sec id="s6_4"><title>2.4. 统计学处理</title><p>采用SPSS 26.0软件对数据进行统计分析。计量资料：呈正态分布的指标用均数 &#177; 标准差( x &#175; &#177; s )表示，组间比较采用单因素方差分析；呈非正态分布的指标用中位数和四分位间距表示(IQR)，组间比较采用Kruskal-Wallis H检验。计数资料用百分率(%)表示，组间比较采用卡方检验或Fisher确切概率法。P &lt; 0.05为差异有统计学意义。</p></sec></sec><sec id="s7"><title>3. 结果</title><sec id="s7_1"><title>3.1. CSP患者不同分型的一般资料比较</title><p>本研究纳入78例CSP患者，依据齐鲁医院分型对于CSP患者进行诊治：I型29例，IIa型21例，IIb型6例，IIIa型10例，IIIb型11例，IIIc型1例。在CSP不同分型中年龄、距离上一次剖宫产时间比较，差异均无统计学意义(P &gt; 0.05)。不同分型中停经时间、剖宫产次数、术前β-HCG水平比较，差异有统计学意义(P &lt; 0.05)。见表2。</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Comparison of general data of different types of CSP patients ( x &#175; &#177; s </title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >I型 (n = 29)</th><th align="center" valign="middle" >IIa型 (n = 21)</th><th align="center" valign="middle" >IIb型 (n = 6)</th><th align="center" valign="middle" >IIIa 型 (n = 10)</th><th align="center" valign="middle" >IIIb型 (n = 11)</th><th align="center" valign="middle" >IIIc型 (n = 1)</th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >年龄(岁)</td><td align="center" valign="middle" >33.59 &#177; 5.14</td><td align="center" valign="middle" >33.95 &#177; 4.03</td><td align="center" valign="middle" >34.33 &#177; 5.16</td><td align="center" valign="middle" >32.60 &#177; 5.06</td><td align="center" valign="middle" >33.91 &#177; 3.78</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >0.978</td></tr><tr><td align="center" valign="middle" >剖宫产次数(次)</td><td align="center" valign="middle" >1.69 &#177; 0.60</td><td align="center" valign="middle" >2.05 &#177; 0.59</td><td align="center" valign="middle" >2.00 &#177; 0</td><td align="center" valign="middle" >1.80 &#177; 0.42</td><td align="center" valign="middle" >1.45 &#177; 0.69</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.021</td></tr><tr><td align="center" valign="middle" >距离上一次剖 宫产时间(年)</td><td align="center" valign="middle" >4.69 &#177; 3.32</td><td align="center" valign="middle" >4.81 &#177; 3.71</td><td align="center" valign="middle" >6.33 &#177; 3.07</td><td align="center" valign="middle" >3.90 &#177; 3.07</td><td align="center" valign="middle" >5.09 &#177; 3.99</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.683</td></tr><tr><td align="center" valign="middle" >停经时间(天)</td><td align="center" valign="middle" >50.59 &#177; 7.39</td><td align="center" valign="middle" >47.76 &#177; 9.36</td><td align="center" valign="middle" >56.83 &#177; 11.27</td><td align="center" valign="middle" >59.90 &#177; 10.46</td><td align="center" valign="middle" >61.45 &#177; 17.52</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >0.004</td></tr><tr><td align="center" valign="middle" >术前血β-HCG 水平(mIU/ml)</td><td align="center" valign="middle" >38,046.38 &#177; 35,900.19</td><td align="center" valign="middle" >25,948.0 &#177; 20,254.63</td><td align="center" valign="middle" >80,143.00 &#177; 2001.11</td><td align="center" valign="middle" >49,715.03 &#177; 33,546.09</td><td align="center" valign="middle" >7864.69 &#177; 16,938.56</td><td align="center" valign="middle" >584.7</td><td align="center" valign="middle" >0.000</td></tr></tbody></table></table-wrap><p>表2. CSP患者不同分型的一般资料比较( x &#175; &#177; s )</p></sec><sec id="s7_2"><title>3.2. CSP患者中不同分型的术中指标、术后恢复的情况比较</title><p>CSP患者的不同分型中，住院天数、住院总费用、术中的出血量、手术时间、术前与术后首次复查血β-HCG下降水平比较，差异均有统计学意义(P &lt; 0.05)。在CSP患者的不同分型中，术后血β-HCG恢复正常的时间比较，差异无统计学意义(P &gt; 0.05)。见表3。依据齐鲁医院分型，CSP患者中I型有16例行超声监护下高风险吸宫术，8例行超声监护下高风险吸宫术 + 宫腔镜手术，3例行腹腔镜监测下高风险吸宫术 + 宫腔镜手术，2例行腹腔镜子宫瘢痕妊娠清除术 + 吸宫术 + 宫腔镜手术。是由于术中见宫腔镜检查宫腔前壁下段见一宽大、较深憩室，憩室左右侧角处见残留妊娠组织，憩室内活动性出血，等离子电切环予以电切，切除过程困难，妊娠组织与肌层致密粘连，分界不清，电凝出血点，予以宫颈注射稀释垂体后叶素6u，缩宫素10u静滴，同时按摩子宫，宫颈外口仍存在多量流血，台下与患者家属沟通术中情况后，遂中转了手术方式。IIa型有2例行超声监护下高风险吸宫术，4例行超声监护下高风险吸宫术 + 宫腔镜手术，8例行腹腔镜监测下高风险吸宫术 + 宫腔镜手术，7例行腹腔镜子宫瘢痕妊娠清除术 + 吸宫术 + 宫腔镜手术。中转手术方式是因为术中见患者阴道壁松弛，无法暴露宫颈，尝试宫腔镜检查，进镜宫颈暴露困难，无法钳夹，遂横行切开子宫前壁下段，见妊娠组织(羊水、胎盘及绒毛)，予以吸引器吸出，并修剪瘢痕处组织，2/0倒刺线连续全层缝合切缘成形子宫，1/0可吸收线加固缝合浆肌层。IIb型中有1例行超声监护下高风险吸宫术 + 宫腔镜手术，2例行腹腔镜监测下高风险吸宫术 + 宫腔镜手术，3例行腹腔镜子宫瘢痕妊娠清除术 + 吸宫术 + 宫腔镜手术；IIIa型中有1例腹腔镜监测下高风险吸宫术 + 宫腔镜手术，9例腹腔镜子宫瘢痕妊娠清除术 + 吸宫术 + 宫腔镜手术。其中1例是药物流产失败后2月，术中见妊娠组织侵蚀至膀胱底，检查有活动性出血，2-0可吸收线缝扎膀胱底止血。术中失血多，予A型RH阳性去白浓缩红细胞3U，冰冻血浆600 ml。1例是吸宫后见瘢痕处明显凹陷，横行切开子宫下段约3 cm，见无明显妊娠组织残留，2/0倒刺线连续全层缝合加固成形子宫。1例是术中行宫腔镜检查，宫腔下段前壁偏左侧见一憩室，较深，见残留妊娠组织及活动性出血，切除困难，术中腹腔镜监测下见宫体前壁下段菲薄。遂宫腔下段至球囊压迫止血，考虑宫腔镜下无法完全切除妊娠组织，需行瘢痕切开术，患者合并残角子宫，告知保留有残角子宫，存在经期腹痛、残角子宫妊娠可能。要求切除残角子宫及左侧输卵管，并行瘢痕切开清除妊娠组织。IIIb型中有11例行腹腔镜子宫瘢痕妊娠清除术 + 吸宫术 + 宫腔镜手术。1例是人工流产术后7月，发现宫腔占位40天，遂行清宫术，术中出血多，输血4u悬浮红细胞，复查阴道彩超宫腔混合回声团块。1例术中出血多，输血去白悬浮红细胞4U，血浆390 ml。1例是5天前在外院行人工流产术，术中出血约700 ml，予子宫动脉栓塞，阴道流血较前减少。IIIc型中有1例行腹腔镜子宫瘢痕妊娠清除术 + 吸宫术 + 宫腔镜手术，本例是人工流产术后，经超声发现子宫瘢痕处包块，大小 &lt; 6 cm，伴有动静脉瘘，患者一般情况稳定，拒绝开腹手术及子宫动脉栓塞治疗，遂行腹腔镜手术治疗。6例是人工流产术后、药物流产失败、子宫动脉栓塞治疗不佳收入我院，依据齐鲁医院分型进行诊治，其中5例是IIIb型，1例是IIIc型。对于CSP患者，依据齐鲁医院分型进行诊治，手术均获得了较好的治疗效果，无因术中大出血而切除子宫。术后血β-HCG恢复正常水平时间：I型(2.03 &#177; 1.02)周，IIa型(2.48 &#177; 2.32)周，IIb型(2.00 &#177; 0.63)周，IIIa型(2.10 &#177; 0.99)周，IIIb型(1.91 &#177; 1.38)周，IIIc型2周。74例CSP患者在术后2月内月经复潮，比例为94.87%，3例CSP患者需要二次手术，3例术中需要中转手术方式，总体治疗成功率为92.3% (72/78)。见表4。</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Comparison of surgical treatment indicators in different types of CS</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >分型</th><th align="center" valign="middle" >I型 (n = 29)</th><th align="center" valign="middle" >IIa型 (n = 21)</th><th align="center" valign="middle" >IIb型 (n = 6)</th><th align="center" valign="middle" >IIIa型 (n = 10)</th><th align="center" valign="middle" >IIIb型 (n = 11)</th><th align="center" valign="middle" >IIIc型 (n = 1)</th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >住院天数(d)</td><td align="center" valign="middle" >2.45 &#177; 1.09</td><td align="center" valign="middle" >3.38 &#177; 0.97</td><td align="center" valign="middle" >4.50 &#177; 1.38</td><td align="center" valign="middle" >4.50 &#177; 0.71</td><td align="center" valign="middle" >5.00 &#177; 1.55</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >住院总费用(元)</td><td align="center" valign="middle" >6733.08 &#177; 4915.00</td><td align="center" valign="middle" >14,635.90 &#177; 6000.63</td><td align="center" valign="middle" >15,640.55 &#177; 3613.75</td><td align="center" valign="middle" >18,159.03 &#177; 2662.84</td><td align="center" valign="middle" >19,849.76 &#177; 3703.84</td><td align="center" valign="middle" >18,624.06</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >术中出血量(ml)</td><td align="center" valign="middle" >20.69 &#177; 36.27</td><td align="center" valign="middle" >29.76 &#177; 20.89</td><td align="center" valign="middle" >75.00 &#177; 50.10</td><td align="center" valign="middle" >222.00 &#177; 379.47</td><td align="center" valign="middle" >112.73 &#177; 229.74</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >0.026</td></tr><tr><td align="center" valign="middle" >手术时间(min)</td><td align="center" valign="middle" >36.48 &#177; 25.07</td><td align="center" valign="middle" >68.43 &#177; 30.71</td><td align="center" valign="middle" >92.50 &#177; 29.11</td><td align="center" valign="middle" >102.40 &#177; 37.03</td><td align="center" valign="middle" >96.82 &#177; 23.90</td><td align="center" valign="middle" >105</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >术前与术后首次复 查血β-HCG下降 水平(mIU/ml)</td><td align="center" valign="middle" >32,922.89 &#177; 29,829.63</td><td align="center" valign="middle" >31,087.15 &#177; 27,984.67</td><td align="center" valign="middle" >67,579.65 &#177; 7249.72</td><td align="center" valign="middle" >52,673.36 &#177; 26,028.52</td><td align="center" valign="middle" >6798.16 &#177; 15,105.06</td><td align="center" valign="middle" >536.50</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >术后血β-HCG 恢复正常时间(周)</td><td align="center" valign="middle" >2.03 &#177; 1.02</td><td align="center" valign="middle" >2.48 &#177; 2.32</td><td align="center" valign="middle" >2.00 &#177; 0.63</td><td align="center" valign="middle" >2.10 &#177; 0.99</td><td align="center" valign="middle" >1.91 &#177; 1.38</td><td align="center" valign="middle" >2.00</td><td align="center" valign="middle" >0.912</td></tr><tr><td align="center" valign="middle" >宫腔内球囊压迫(n)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >输血治疗(n)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >二次手术(n)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >中转手术(n)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >子宫动脉栓塞(n)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >术后2月内 月经复潮(n)</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >是否残留(n)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >治疗成功率(%)</td><td align="center" valign="middle" >93.1</td><td align="center" valign="middle" >90.5</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >90</td><td align="center" valign="middle" >90.1</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>表3. CSP不同分型中的手术治疗指标比较</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Surgical methods of different types of treatment for CSP patient</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >分型</th><th align="center" valign="middle" >I型 (n = 29)</th><th align="center" valign="middle" >IIa型 (n = 21)</th><th align="center" valign="middle" >IIb型 (n = 6)</th><th align="center" valign="middle" >IIIa型 (n = 10)</th><th align="center" valign="middle" >IIIb型 (n = 11)</th><th align="center" valign="middle" >IIIc型 (n = 1)</th><th align="center" valign="middle" >P</th></tr></thead><tr><td align="center" valign="middle" >超声监护下高风险吸宫术(n)</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle"  rowspan="4"  >0.000</td></tr><tr><td align="center" valign="middle" >超声监护下高风险吸宫术 + 宫腔镜手术(n)</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >腹腔镜监测下高风险吸宫术 + 宫腔镜手术(n)</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >腹腔镜子宫瘢痕妊娠清除术 + 吸宫术 + 宫腔镜手术(n)</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >1</td></tr></tbody></table></table-wrap><p>表4. CSP患者不同分型治疗的手术方式</p></sec></sec><sec id="s8"><title>4. 讨论</title><p>剖宫产术后子宫瘢痕妊娠是剖宫产术后一种远期的严重并发症，指孕囊、受精卵或胚胎着床于既往剖宫产术后的子宫切口瘢痕，是一种特殊类型的异位妊娠 [<xref ref-type="bibr" rid="hanspub.43255-ref3">3</xref>]。随着我国“二孩政策”的开放、剖宫产率的增加以及经阴道超声检查等影像学水平的提高，CSP的发生率在逐年地升高。若诊断不及时，治疗方式不当，I型病例可以逐渐发展为严重的III型，会导致难治性大出血、输血、子宫破裂，胎盘植入、重度胎盘粘连、邻近的器官损伤，更严重者子宫切除及危及生命 [<xref ref-type="bibr" rid="hanspub.43255-ref4">4</xref>] [<xref ref-type="bibr" rid="hanspub.43255-ref5">5</xref>]。所以对于CSP的诊疗原则：早诊断，早终止，早清除 [<xref ref-type="bibr" rid="hanspub.43255-ref1">1</xref>]。对于既往有剖宫产史的女性，一经确诊为CSP，需要积极地处理清除妊娠物，可以有效减少并发症的发生，保留患者的生育能力 [<xref ref-type="bibr" rid="hanspub.43255-ref6">6</xref>]。现治疗的方法有药物治疗、手术治疗、微创治疗以及这些治疗的各种组合应用 [<xref ref-type="bibr" rid="hanspub.43255-ref7">7</xref>]，有刮宫术、宫腔镜检查、腹腔镜检查、经阴道手术、开腹手术、子宫动脉栓塞(UAE)、局部或全身应用甲氨蝶呤(MTX)、高强度聚焦超声(HIFU)等。但目前尚未报道最佳的治疗方案。</p><p>目前临床上CSP分型有2000年的Vial分型 [<xref ref-type="bibr" rid="hanspub.43255-ref8">8</xref>]，根据妊娠囊种植子宫瘢痕处的位置及其生长的方向，分为内生型与外生型，分型不太具体，对临床工作的实际的指导价值有限。有时与妊娠滋养细胞疾病难以鉴别，容易误诊，对患者造成不必要的损害。2012年向阳等 [<xref ref-type="bibr" rid="hanspub.43255-ref9">9</xref>] 根据多年临床处理经验，分为I、II、III型，即分为宫腔内的孕囊存活型、瘢痕处肌层内孕囊型、包块型或类滋养细胞疾病型。我国2016年的专家共识提出，孕囊部分着床于剖宫产术后子宫瘢痕处，最小前壁肌层的厚度 &gt; 3 mm为I型，瘢痕处肌层的厚度 ≤ 3 mm为II型，若孕囊进一步的完全着床于剖宫产术后子宫瘢痕处并凸向膀胱的方向，宫腔、宫颈管空虚，孕囊与膀胱之间的肌层不清或缺失为III型 [<xref ref-type="bibr" rid="hanspub.43255-ref1">1</xref>]。此分型根据超声检查，明确孕囊的位置、生长方向、与膀胱之间的肌层的厚度及周围的血流情况，但是I型手术前均建议进行甲氨蝶呤(MTX)预处理，II型及III型CSP术前均建议进行预处理，包括MTX治疗、子宫动脉栓塞(UAE)，过分强调了术前MTX或UAE的预处理的重要性，对于孕囊或病灶的大小缺乏具体的说明，在临床的处理仍旧存在困惑。</p><p>本研究分型是2019年康彦君等 [<xref ref-type="bibr" rid="hanspub.43255-ref10">10</xref>] 根据多年的实际临床处理经验提出的齐鲁医院分型：1) I型为最小前壁肌层厚度 ≥ 3 mm，无论包块或妊娠囊平均直径的大小，首选的推荐的治疗方式是超声监视下吸宫术 &#177; 宫腔镜手术；2) II型为最小前壁肌层厚度1~3 mm，包块或妊娠囊平均直径 ≤ 3 cm，推荐手术的方式是超声监视下吸宫术 + 宫腔镜手术。包块或妊娠囊平均直径 &gt; 3 cm，推荐的手术方式是腹腔镜监视下吸宫术 + 宫腔镜手术；或经阴道前穹隆切开术病灶清除术；必要时瘢痕缺陷修补术或经阴手术。3) III型为最小前壁肌层厚度 &lt; 1mm，包块或妊娠囊平均直径 ≤ 6 cm，活胚孕囊，推荐的手术方式是腹腔镜下瘢痕妊娠清除术 + 吸宫术；或经阴道前穹隆切开病灶清除术。包块或妊娠囊平均直径 ≤ 6 cm，停育孕囊或混合包块，推荐的手术方式是腹腔镜下瘢痕妊娠病灶清除术 + 吸宫术；或经阴道前穹隆切开病灶清除术。包块或妊娠囊平均直径 &gt; 6 cm，或伴有动静脉瘘，推荐的手术方式是开腹手术或子宫动脉栓塞后腹腔镜手术。有文献报道 [<xref ref-type="bibr" rid="hanspub.43255-ref11">11</xref>]，对比常见的CSP分型方法，发现实用临床的分型对手术方式的选择上有较高的指导价值，并且预测术中的出血量的能力较强，2016年的专家共识提出的CSP分型中，在根据剖宫产术后子宫瘢痕厚度、妊娠囊生长的方向等基础上，更加细化地加入了妊娠囊或病灶的大小，使得在临床的处理决策上更加具体清晰，有利于对于CSP的患者个体化的诊治。本文纳入了依据齐鲁医院分型进行诊治的78例CSP患者，CSP患者术后2月内月经复潮，比例为94.87%，需要二次手术比例占3.8%，术中需要中转手术方式的比例为3.8%，总体治疗成功率为92.3%。Doroszewska K等 [<xref ref-type="bibr" rid="hanspub.43255-ref12">12</xref>] 回顾分析了23例CSP患者，9例(39%)出现阴道出血，4例(17%)出现腹痛。有2例患者在系统性应用MTX后的4周、6周出现阴道流血再次入院治疗，行宫腔镜手术清除子宫瘢痕处妊娠组织，所以在血液动力学不稳定或药物治疗无效时进行手术治疗，可以进一步提高治疗的成功率，减少并发症发生的风险。还分析了CSP的临床特点、诊断、各种治疗方法和临床结果，治疗方法应考虑妊娠囊的大小、子宫肌层的连续性、血β-HCG的水平、生育能力的保留、患者的生命体征状态及就诊医院的治疗经验。Belmajdoub M等 [<xref ref-type="bibr" rid="hanspub.43255-ref13">13</xref>] 报道，1例CSP患者在症状加重、盆腔疼痛加剧，开腹手术行妊娠组织清除术后，随访2周后，hCG恢复为阴性，一般情况恢复良好。</p><p>Birch Petersen K等 [<xref ref-type="bibr" rid="hanspub.43255-ref14">14</xref>] 系统分析纳入了2037例CSP患者，研究了CSP的治疗方式，重点是不同治疗方式的影响与并发症。腹腔镜手术的治疗的成功率97.1%，宫腔镜手术的成功率83.2%，系统性应用MTX的成功率75.2%，局部应用MTX的成功率64.9%。对于CSP治疗的方法建议有经阴道清除子宫瘢痕处妊娠物、经腹腔镜下、子宫动脉栓塞后结合宫腔镜、经宫腔镜下等，有较好的研究证据支持，有效性及安全性 [<xref ref-type="bibr" rid="hanspub.43255-ref15">15</xref>] [<xref ref-type="bibr" rid="hanspub.43255-ref16">16</xref>] [<xref ref-type="bibr" rid="hanspub.43255-ref17">17</xref>]。Timor-Tritsch IE等 [<xref ref-type="bibr" rid="hanspub.43255-ref5">5</xref>] 分析了单剂量的系统注射甲氨蝶呤，通常无效，而且会延迟最终的治疗，子宫动脉栓塞术不能单独作为一线治疗，但对于由于持续出血的紧急情况可以辅助治疗。Cal&#236; G等 [<xref ref-type="bibr" rid="hanspub.43255-ref18">18</xref>] 荟萃分析中提出了胚胎是否有活性，对于CSP患者来说出现严重的出血、早期得子宫破裂、子宫切除等并发症相关。在有关研究中，宫腔镜手术、腹腔镜手术对于治疗CSP，术中出血较少，术中时间段、住院天数短及住院总费用少的优势，有较好的安全性及治疗效果 [<xref ref-type="bibr" rid="hanspub.43255-ref19">19</xref>] [<xref ref-type="bibr" rid="hanspub.43255-ref20">20</xref>] [<xref ref-type="bibr" rid="hanspub.43255-ref21">21</xref>]。</p><p>本文纳入了我院78例CSP患者，依据齐鲁医院分型进行诊治，术前没有常规MTX预处理，术中无子宫切除术的病例，术后随诊2周患者的血清β-HCG水平基本恢复正常，94.87%在2月内月经复潮，总体治疗成功率为92.3%，在临床实际的应中有确切的可行性以及高成功率，此分型兼顾了孕囊或病灶的大小、分型直观易理解、可制定个体化的治疗策略，并且没有过分强调术前MTX或UAE的预处理的重要性，因此可以减少MTX引起的副反应和UAE对卵巢功能及子宫内膜等远期损害，减少严重并发症的发生和对患者的创伤，对于CSP患者的生育能力尽最大努力的保留。剖宫产术后子宫瘢痕处妊娠的诊疗原则：早诊断、早终止、早清除，能够改善患者的预后。本研究是依据齐鲁医院分型对CSP患者进行分型诊疗，未MTX预处理，手术治疗后均取得不错的治疗效果，此分型适用于临床，简便可行，能够对患者的病情充分的评估，推荐的治疗方案，成功率高，并发症少，值得进一步应用于临床及推广。</p><p>本研究不足是样本量小，更需要多中心、前瞻性对照研究进一步的综述证实，在对于CSP的治疗中可以得出统一明确的诊疗方案。</p></sec><sec id="s9"><title>文章引用</title><p>李冬梅,王苏荣,刘天凤. 齐鲁医院分型诊治78例子宫瘢痕妊娠的临床观察Clinical Observation of 78 Cases of Cesarean Scar Pregnancy Diagnosed and Treated by Typing in Qilu Hospital[J]. 临床医学进展, 2021, 11(06): 2730-2737. https://doi.org/10.12677/ACM.2021.116395</p></sec><sec id="s10"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.43255-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">中华医学会妇产科学分会计划生育学组. 剖宫产术后子宫瘢痕妊娠诊治专家共识(2016) [J]. 中华妇产科杂志, 2016, 51(8): 568-572.</mixed-citation></ref><ref id="hanspub.43255-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Seow, K.M., Huang, L.W., Lin, Y.H., Lin, M.Y., Tsai, Y.L. and Hwang, J.L. (2004) Cesarean Scar Pregnancy: Issues in Management. Ultrasound in Obstetrics &amp; Gynecology, 23, 247-253. &lt;br&gt;https://doi.org/10.1002/uog.974</mixed-citation></ref><ref id="hanspub.43255-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Gonzalez, N. and Tulandi, T. (2017) Cesarean Scar Pregnancy: A Systematic Review. Journal of Minimally Invasive Gynecology, 24, 731-738. &lt;br&gt;https://doi.org/10.1016/j.jmig.2017.02.020</mixed-citation></ref><ref id="hanspub.43255-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Cali, G., Forlani, F., Timor-Tritsch, I.E., Palacios-Jaraquemada, J., Minneci, G. and D’Antonio, F. (2017) Natural History of Cesarean Scar Pregnancy on Prenatal Ultrasound: The Crossover Sign. Ultrasound in Obstetrics &amp; Gynecology, 50, 100-104. &lt;br&gt;https://doi.org/10.1002/uog.16216</mixed-citation></ref><ref id="hanspub.43255-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Timor-Tritsch, I.E., Monteagudo, A., Calì, G., D’Antonio, F. and Agten, A.K. (2019) Cesarean Scar Pregnancy: Patient Counseling and Management. Obstetrics and Gynecology Clinics of North America, 46, 813-828.  
&lt;br&gt;https://doi.org/10.1016/j.ogc.2019.07.010</mixed-citation></ref><ref id="hanspub.43255-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">López-Girón, M.C., Nieto-Calvache, A.J., Quintero, J.C., Benavides-Calvache, J.P., Victoria-Borrero, A., López-Tenorio, J. (2020) Cesarean Scar Pregnancy, the Importance of Immediate Treatment. The Journal of Maternal-Fetal &amp; Neonatal Medicine, 1-4. &lt;br&gt;https://doi.org/10.1080/14767058.2020.1742691</mixed-citation></ref><ref id="hanspub.43255-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Miller, R., Timor-Tritsch, I.E, Gyamfi-Bannerman, C. (2020) Society for Maternal-Fetal Medicine (SMFM) Consult Series #49: Cesarean Scar Pregnancy. American Journal of Obstetrics &amp; Gynecology, 222, B2-B14.  
&lt;br&gt;https://doi.org/10.1016/j.ajog.2020.01.030</mixed-citation></ref><ref id="hanspub.43255-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Vial, Y., Petignat, P. and Hohlfeld, P. (2000) Pregnancy in a Cesarean Scar. Ultrasound in Obstetrics &amp; Gynecology, 16, 592-593. &lt;br&gt;https://doi.org/10.1046/j.1469-0705.2000.00300-2.x</mixed-citation></ref><ref id="hanspub.43255-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">向阳. 关于剖宫产瘢痕妊娠的分型与治疗方法的选择[J]. 中国妇产科临床杂志, 2012,13(6): 401-404.</mixed-citation></ref><ref id="hanspub.43255-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">康彦君, 班艳丽, 张腾, 刘芬, 张贵宇, 张小磊, 等. 子宫瘢痕妊娠实用临床分型及应用价值探讨[J]. 现代妇产科进展, 2019, 28(10): 731-735.</mixed-citation></ref><ref id="hanspub.43255-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">刘宝, 胡丽娜, 池余刚, 黄健容, 申丽媛, 黄婵. 不同子宫瘢痕妊娠分型方法对选择手术方式的指导作用分析[J]. 现代妇产科进展, 2021, 30(1): 33-36.</mixed-citation></ref><ref id="hanspub.43255-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Doroszewska, K., Milewicz, T., Bereza, T., Horbaczewska, A., Komenda, J., Kłosowicz, E., et al. (2019) Cesarean Scar Pregnancy—Various Methods of Treatment. Folia Medica Cracoviensia, 59, 5-14.</mixed-citation></ref><ref id="hanspub.43255-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Belmajdoub, M., Jayi S., Chaara, H. and Melhouf, A. (2018) Grossesse sur cicatrice de césarienne: À propos d’un cas et revue de la littérature [Cesarean-Scar Pregnancy: About a Case and Literature Review]. The Pan African Medical Journal, 31, Article No. 227. &lt;br&gt;https://doi.org/10.11604/pamj.2018.31.227.12905</mixed-citation></ref><ref id="hanspub.43255-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Birch Petersen, K., Hoffmann, E., Rifbjerg Larsen, C. and Svarre Nielsen, H. (2016) Cesarean Scar Pregnancy: A Systematic Review of Treatment Studies. Fertility and Sterility, 105, 958-967.  
&lt;br&gt;https://doi.org/10.1016/j.fertnstert.2015.12.130</mixed-citation></ref><ref id="hanspub.43255-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">徐郑军, 孙云, 侯标. 不同治疗手段对剖宫产术后子宫瘢痕部位妊娠的临床价值分析[J]. 中国妇产科临床杂志, 2021, 22(1): 82-83.</mixed-citation></ref><ref id="hanspub.43255-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">蔡昌南. 宫腔镜治疗部分Ⅱ型子宫瘢痕妊娠的临床观察[J]. 中国医疗器械信息, 2020, 26(22): 27-28.</mixed-citation></ref><ref id="hanspub.43255-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">蔡惠春, 张振威. 不同分型早期剖宫产术后子宫瘢痕妊娠的手术治疗分析[J]. 中国现代医生, 2020, 58(29): 71-74.</mixed-citation></ref><ref id="hanspub.43255-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Calì, G., Timor-Tritsch, I.E., Palacios-Jaraquemada, J., Monteaugudo, A., Buca, D., Forlani, F., et al. (2018) Outcome of Cesarean Scar Pregnancy Managed Expectantly: Systematic Review and Meta-Analysis. Ultrasound in Obstetrics &amp; Gynecology, 51, 169-175. &lt;br&gt;https://doi.org/10.1002/uog.17568</mixed-citation></ref><ref id="hanspub.43255-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">曾继花. 应用宫腔镜治疗剖宫产术后子宫瘢痕妊娠的临床有效性研究[J]. 数理医药学杂志, 2021, 34(1): 39-40.</mixed-citation></ref><ref id="hanspub.43255-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">董君肖, 韩玉英, 王庆一. 腹腔镜联合宫腔镜手术治疗子宫瘢痕妊娠的临床效果[J]. 中国当代医药, 2020, 27(36): 109-112.</mixed-citation></ref><ref id="hanspub.43255-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">陆伟, 陈汝君, 李怀芳, 童晓文. 不同方案治疗剖宫产术后子宫瘢痕妊娠28例临床分析[J]. 现代妇产科进展, 2017, 26(10): 773-776.</mixed-citation></ref></ref-list></back></article>